GENESIS HEALTHCARE INC - CL A COM (GENN)

CUSIP: 37185X106

Q4 2019 13F Holders as of 31 Dec 2019

Type / Class
Equity / CL A COM
Total 13F shares
35,102,743
Share change
+1,906,721
Total reported value
$57,569,983
Price per share
$1.64
Number of holders
68
Value change
+$3,228,187
Number of buys
39
Number of sells
21

Quarterly Holders Quick Answers

What is CUSIP 37185X106?
CUSIP 37185X106 identifies GENN - GENESIS HEALTHCARE INC - CL A COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of GENESIS HEALTHCARE INC - CL A COM (GENN) as of Q4 2019

As of 31 Dec 2019, GENESIS HEALTHCARE INC - CL A COM (GENN) was held by 68 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 35,102,743 shares. The largest 10 holders included V3 Capital Management, L.P., BlackRock Inc., First Washington CORP, RENAISSANCE TECHNOLOGIES LLC, VANGUARD GROUP INC, Chevy Chase Trust Holdings, Inc., ACADIAN ASSET MANAGEMENT LLC, STATE STREET CORP, PANAGORA ASSET MANAGEMENT INC, and NORTHERN TRUST CORP. This page lists 68 institutional shareholders reporting positions in this security for the Q4 2019 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.